Related Experiment Video
Updated: Nov 10, 2025

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
Changes in Gene Expression Profiling and Phenotype in Aged Multidrug Resistance Protein 4-Deficient Mouse Retinas
Kyung Woo Kim1, Sentaro Kusuhara1, Atsuko Katsuyama-Yoshikawa1
1Division of Ophthalmology, Department of Surgery, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan.
Abstract:
Multidrug resistance protein 4 (MRP4) is an energy-dependent membrane transporter responsible for cellular efflux of a broad range of xenobiotics and physiological substrates. In this trial, we aimed to investigate the coeffects of aging and MRP4 deficiency using gene expression microarray and morphological and electrophysiological analyses of mouse retinas. Mrp4-knockout (null) mice and wild-type (WT) mice were reared in the same conditions to 8-12 weeks (young) or 45-55 weeks (aged). Microarray analysis identified 186 differently expressed genes from the retinas of aged Mrp4-null mice as compared to aged WT mice, and subsequent gene ontology and KEGG pathway analyses showed that differently expressed genes were related to lens, eye development, vision and transcellular barrier functions that are involved in metabolic pathways or viral infection pathways. No significant change in thickness was observed for each retinal layer among young/aged WT mice and young/aged Mrp4-null mice. Moreover, immunohistochemical analyses of retinal cell type did not exhibit an overt change in the cellular morphology or distribution among the four age/genotype groups, and the electroretinogram responses showed no significant differences in the amplitude or the latency between aged WT mice and aged Mrp4-null mice. Aging would be an insufficient stress to cause some damage to the retina in the presence of MRP4 deficiency.
Insights
Aging does not significantly damage the retina in multidrug resistance protein 4 (MRP4) deficient mice. Gene expression and retinal analyses showed no adverse effects from MRP4 deficiency combined with aging.
Area of Science:
- Ophthalmology
- Molecular Biology
- Genetics
Background:
- Multidrug resistance protein 4 (MRP4) is a key transporter involved in cellular efflux.
- Understanding MRP4's role in aging and retinal health is crucial for age-related vision research.
Purpose of the Study:
- To investigate the combined effects of aging and MRP4 deficiency on mouse retinas.
- To analyze gene expression, morphology, and electrophysiology in aged and young Mrp4-knockout mice.
Main Methods:
- Gene expression microarray analysis of aged Mrp4-null versus wild-type (WT) mouse retinas.
- Morphological analysis using immunohistochemistry and retinal layer thickness measurements.
- Electrophysiological assessment via electroretinogram (ERG) testing.
Main Results:
- Microarray identified 186 differentially expressed genes in aged Mrp4-null retinas, linked to eye development, vision, and metabolic pathways.
- No significant changes in retinal layer thickness, cell morphology, or distribution were observed across groups.
- ERG responses showed no significant differences between aged WT and aged Mrp4-null mice.
Conclusions:
- Aging alone is insufficient to induce retinal damage in the absence of functional MRP4.
- MRP4 deficiency does not exacerbate age-related retinal changes under the tested conditions.
- Further research may explore other stressors in conjunction with MRP4 deficiency.

